|
|
| (21 intermediate revisions by the same user not shown) |
| Line 1: |
Line 1: |
| ==4. Final thoughts and additional resources== | | <div class="nonumtoc">__TOC__</div> |
| | {{ombox |
| | | type = notice |
| | | style = width: 960px; |
| | | text = This is sublevel35 of my sandbox, where I play with features and test MediaWiki code. If you wish to leave a comment for me, please see [[User_talk:Shawndouglas|my discussion page]] instead.<p></p> |
| | }} |
|
| |
|
| | | ==Sandbox begins below== |
| ===4.1 Final thoughts=== | |
| | |
| | |
| ===4.2 Key guidance documents===
| |
| | |
| * {{cite web |url=https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html |title=Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19) |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=24 March 2020}}
| |
| | |
| * {{cite web |url=https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html |title=Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19) |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=24 March 2020}}
| |
| | |
| * {{cite web |url=https://www.cdc.gov/coronavirus/2019-nCoV/lab/lab-biosafety-guidelines.html |title=Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19) |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=31 March 2020}}
| |
| | |
| * {{cite web |url=https://www.osha.gov/Publications/OSHA3990.pdf |format=PDF |title=Guidance on Preparing Workplaces for COVID-19 |work=OSHA 3990-03 2020 |author=Occupational Safety and Health Administration |publisher=Occupational Safety and Health Administration |date=March 2020}}
| |
| | |
| * {{cite web |url=https://www.gov.uk/government/publications/wuhan-novel-coronavirus-guidance-for-clinical-diagnostic-laboratories |title=COVID-19: Guidance for sampling and for diagnostic laboratories |author=Public Health England |publisher=U.K Government |date=28 March 2020}}
| |
| | |
| * {{cite web |url=https://www.health.gov.au/resources/publications/phln-guidance-on-laboratory-testing-for-sars-cov-2-the-virus-that-causes-covid-19 |title=PHLN guidance on laboratory testing for SARS-CoV-2 (the virus that causes COVID-19) |author=Public Health Laboratory Network |publisher=Department of Health, Australian Government |date=01 April 2020}}
| |
| | |
| * {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-face-masks-and-respirators-during-coronavirus-disease-covid-19-public-health |title=Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency |work=FDA-2020-D-1138-0013 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=25 March 2020}}
| |
| | |
| * {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-gowns-other-apparel-and-gloves-during-coronavirus-disease-covid-19-public-health |title=Enforcement Policy for Gowns, Other Apparel, and Gloves During the Coronavirus Disease (COVID-19) Public Health Emergency |work=FDA-2020-D-1138-0023 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=30 March 2020}}
| |
| | |
| * {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-diagnostic-tests-coronavirus-disease-2019-during-public-health-emergency |title=Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency |work=FDA-2020-D-0987-0012 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=16 March 2020}}
| |
| | |
| * {{cite web |url=https://apps.who.int/iris/handle/10665/331500 |title=Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 19 March 2020 |work=WHO/WPE/GIH/2020.2 |author=World Health Organization, et al. |publisher=World Health Organization |date=19 March 2020}}
| |
| | |
| * {{cite web |url=https://apps.who.int/iris/handle/10665/331501 |title=Laboratory testing for coronavirus disease (COVID-19) in suspected human cases: Interim guidance, 19 March 2020 |work=WHO/COVID-19/laboratory/2020.5 |author=World Health Organization, et al. |publisher=World Health Organization |date=19 March 2020}}
| |
| | |
| ===4.3 Web portals===
| |
| ====4.3.1 U.S. agency portals====
| |
| | |
| * [https://www.cdc.gov/coronavirus/2019-ncov/hcp/index.html Coronavirus Disease 2019 (COVID-19) - Information for Healthcare Professionals] (CDC)
| |
| * [https://www.cdc.gov/coronavirus/2019-nCoV/lab/index.html Coronavirus Disease 2019 (COVID-19) - Information for Laboratories] (CDC)
| |
| * [https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-related-guidance-documents-industry-fda-staff-and-other-stakeholders COVID-19-Related Guidance Documents for Industry, FDA Staff, and Other Stakeholders] (FDA)
| |
| * [https://www.fema.gov/coronavirus Coronavirus (COVID-19) Response] (FEMA)
| |
| | |
| ====4.3.2 U.S. state and territory portals====
| |
| | |
| * [https://governor.alabama.gov/newsroom/covid-19/ Alabama]
| |
| * [http://dhss.alaska.gov/dph/Epi/id/Pages/COVID-19/default.aspx Alaska]
| |
| * [https://az.gov/government-0 Arizona]
| |
| * [https://govstatus.egov.com/ar-covid-19 Arkansas]
| |
| * [https://covid19.ca.gov/ California]
| |
| * [https://covid19.colorado.gov/ Colorado]
| |
| * [https://portal.ct.gov/coronavirus Connecticut]
| |
| * [https://coronavirus.delaware.gov/ Delaware]
| |
| * [https://coronavirus.dc.gov/ District of Columbia]
| |
| * [https://floridahealthcovid19.gov/ Florida]
| |
| * [https://georgia.gov/covid-19-state-services-georgia Georgia]
| |
| * [https://hawaiicovid19.com/ Hawaii]
| |
| * [https://coronavirus.idaho.gov/ Idaho]
| |
| * [https://coronavirus.illinois.gov/ Illinois]
| |
| * [https://coronavirus.in.gov/ Indiana]
| |
| * [https://coronavirus.iowa.gov/ Iowa]
| |
| * [https://govstatus.egov.com/coronavirus Kansas]
| |
| * [https://govstatus.egov.com/kycovid19 Kentucky]
| |
| * [https://gov.louisiana.gov/coronavirus/ Louisiana]
| |
| * [https://www.maine.gov/governor/mills/covid-19 Maine]
| |
| * [https://coronavirus.maryland.gov/ Maryland]
| |
| * [https://www.mass.gov/info-details/covid-19-updates-and-information Massachusetts]
| |
| * [https://www.michigan.gov/coronavirus/ Michigan]
| |
| * [https://www.health.state.mn.us/diseases/coronavirus/index.html Minnesota]
| |
| * [https://www.coronavirus.ms.gov/ Mississippi]
| |
| * [https://health.mo.gov/living/healthcondiseases/communicable/novel-coronavirus/ Missouri]
| |
| * [https://covid19.mt.gov/ Montana]
| |
| * [http://dhhs.ne.gov/Pages/Coronavirus.aspx Nebraska]
| |
| * [https://nvhealthresponse.nv.gov/ Nevada]
| |
| * [https://www.nh.gov/covid19/ New Hampshire]
| |
| * [https://covid19.nj.gov/ New Jersey]
| |
| * [https://www.newmexico.gov/ New Mexico]
| |
| * [https://coronavirus.health.ny.gov/home New York]
| |
| * [https://www.ncdhhs.gov/divisions/public-health/coronavirus-disease-2019-covid-19-response-north-carolina North Carolina]
| |
| * [https://ndresponse.gov/covid-19-resources North Dakota]
| |
| * [https://coronavirus.ohio.gov/wps/portal/gov/covid-19/home Ohio]
| |
| * [https://coronavirus.health.ok.gov/ Oklahoma]
| |
| * [https://govstatus.egov.com/or-covid-19 Oregon]
| |
| * [https://www.pa.gov/guides/responding-to-covid-19/ Pennsylvania]
| |
| * [https://health.ri.gov/covid/ Rhode Island]
| |
| * [https://www.scdhec.gov/infectious-diseases/viruses/coronavirus-disease-2019-covid-19 South Carolina]
| |
| * [https://covid.sd.gov/ South Dakota]
| |
| * [https://www.tn.gov/governor/covid-19.html Tennessee]
| |
| * [https://texas.gov/#covid19 Texas]
| |
| * [https://coronavirus.utah.gov/ Utah]
| |
| * [https://www.healthvermont.gov/response/infectious-disease/2019-novel-coronavirus Vermont]
| |
| * [https://www.virginia.gov/coronavirus/ Virginia]
| |
| * [https://coronavirus.wa.gov/ Washington]
| |
| * [https://dhhr.wv.gov/COVID-19/Pages/default.aspx West Virginia]
| |
| * [https://www.dhs.wisconsin.gov/covid-19/index.htm Wisconsin]
| |
| * [https://covid19.wyo.gov/ Wyoming]
| |
| | |
| '''U.S. territories'''
| |
| | |
| * [https://www.americansamoa.gov/ American Samoa]
| |
| * [https://ghs.guam.gov/coronavirus-covid-19 Guam]
| |
| * [https://www.chcc.gov.mp/coronavirusinformation.php Northern Mariana Islands]
| |
| * [https://www.facebook.com/puertoricomedicaltaskforcecovid19/ Puerto Rico]
| |
| * [https://doh.vi.gov/covid19usvi Virgin Islands]
| |
| | |
| | |
| ====4.3.3 Other national and multinational portals====
| |
| | |
| * [https://www.australia.gov.au/ Australian Government]
| |
| * [https://www.ecdc.europa.eu/en/coronavirus European CDC]
| |
| * [https://www.canada.ca/en/public-health/services/diseases/coronavirus-disease-covid-19.html Government of Canada]
| |
| * [https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/newpage_00032.html Government of Japan]
| |
| * [https://coronavirus.gob.mx/ Government of México]
| |
| | |
| '''World Health Organization (WHO) and regionals'''
| |
| | |
| * [https://www.who.int/emergencies/diseases/novel-coronavirus-2019 WHO]
| |
| * [https://www.afro.who.int/health-topics/coronavirus-covid-19 WHO Africa]
| |
| * [https://www.paho.org/en/topics/coronavirus-infections/coronavirus-disease-covid-19 WHO Americas]
| |
| * [http://www.emro.who.int/health-topics/corona-virus/index.html WHO Eastern Mediterranean]
| |
| * [http://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19 WHO Europe]
| |
| * [https://www.who.int/southeastasia/outbreaks-and-emergencies/novel-coronavirus-2019 WHO South-East Asia]
| |
| * [https://www.who.int/westernpacific/emergencies/covid-19 WHO Western Pacific]
| |
| | |
| ===4.4 Key journal articles===
| |
| | |
| * {{cite journal |title=Safety considerations in the laboratory testing of specimens suspected or known to contain the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |journal=American Journal of Clinical Pathology |author=Iwen, P.C.; Stiles, K.L.; Pantella, M.A. |at=aqaa047 |year=2020 |doi=10.1093/ajcp/aqaa047 |pmid=32190890}}
| |
| | |
| * {{cite journal |title=Laboratory diagnosis of emerging human coronavirus infections – The state of the art |journal=Emerging Microbes & Infections |author=Loeffelholz, M.J.; Tang, T.-W. |volume=9 |issue=1 |pages=747–56 |year=2020 |doi=10.1080/22221751.2020.1745095 |pmid=32196430}}
| |
| | |
| ===4.5 Public health lab directory===
| |
| | |
| | |
| ===4.6 National and global resources===
| |
| | |
| | |
| ===4.7 Public health laboratory informatics solutions===
| |
